Determining Clinically-Viable Biomarkers for Ischaemic Stroke Through a Mechanistic and Machine Learning Approach

Ivan Benemerito1,2, Ana Paula Narata3, Andrew Narracott4,5

  • 1INSIGNEO Institute for In Silico Medicine, The University of Sheffield, Sheffield, UK. i.benemerito@sheffield.ac.uk.